Objectives
If screening leads to breast cancer being discovered at an earlier stage, less extensive initial treatment and lower costs can be expected. On the other hand, if screening prolongs life expectancy and thus prolongs the period when the patient needs treatment, higher total costs may occur.
Outcomes
The outcome of the project is breast cancer treatment costs from diagnosis to death related to the time of screening and stage of diagnosis.
Background
This project is one out of seven projects that contribute to the evaluation of the Norwegian Mammography Screening Programme.
Financing
The project is financed through Norwegian Research Council, with funding from The Ministry of Health and Care Services.
Cooperation
This project is a joint effort between the Health Economics Research Programme at the University of Oslo and Department of Health Management and Health Economics at the University of Oslo.
Start - Finish
2009.07.01 - 2011.09.01